Velcade, Doxil and Thalidomide (VDT) is an effective salvage regimen for patients with relapsed and refractory multiple myeloma

被引：22

作者：

Chanan-Khan, A ^{[1
]}

Miller, KC ^{[1
]}

机构：

[1] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA

来源：

LEUKEMIA & LYMPHOMA | 2005年 / 46卷 / 07期

关键词：

D O I：

10.1080/10428190500097086

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1103 / 1104

页数：2

共 9 条

[1] Thalidomide and dexamethasone for resistant multiple myeloma [J].

Anagnostopoulos, A ;

Weber, D ;

Rankin, K ;

Delasalle, K ;

Alexanian, R .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (05) :768-771

[2] Moving disease biology from the lab to the clinic [J].

Anderson, KC .

CANCER, 2003, 97 (03) :796-801

[3] The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: An evidence-based review [J].

Hahn, T ;

Wingard, JR ;

Anderson, KC ;

Bensinger, WI ;

Berenson, JR ;

Brozeit, G ;

Carver, JR ;

Kyle, RA ;

McCarthy, PL .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (01) :4-37

[4] Novel therapeutic approaches for multiple myeloma [J].

Hideshima, T ;

Richardson, P ;

Anderson, KC .

IMMUNOLOGICAL REVIEWS, 2003, 194 (01) :164-176

[5] Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu [J].

Hideshima, T ;

Akiyama, M ;

Hayashi, T ;

Richardson, P ;

Schlossman, R ;

Chauhan, D ;

Anderson, KC .

BLOOD, 2003, 101 (02) :703-705

[6]

Orlowski Robert Z, 2004, Expert Rev Anticancer Ther, V4, P171, DOI 10.1586/14737140.4.2.171

[7] Advances in the treatment of multiple myeloma: The role of thalidomide [J].

Ribas, C ;

Colleoni, GWB .

LEUKEMIA & LYMPHOMA, 2003, 44 (02) :291-298

[8] A phase 2 study of bortezomib in relapsed, refractory myeloma [J].

Richardson, PG ;

Barlogie, B ;

Berenson, J ;

Singhal, S ;

Jagannath, S ;

Irwin, D ;

Rajkumar, SV ;

Srkalovic, G ;

Alsina, M ;

Alexanian, R ;

Siegel, D ;

Orlowski, RZ ;

Kuter, D ;

Limentani, SA ;

Lee, S ;

Hideshima, T ;

Esseltine, DL ;

Kauffman, M ;

Adams, J ;

Schenkein, DP ;

Anderson, KC .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2609-2617

[9] Antitumor activity of thalidomide in refractory multiple myeloma. [J].

Singhal, S ;

Mehta, J ;

Desikan, R ;

Ayers, D ;

Roberson, P ;

Eddlemon, P ;

Munshi, N ;

Anaissie, E ;

Wilson, C ;

Dhodapkar, M ;

Zeldis, J ;

Barlogie, B ;

Siegel, D ;

Crowley, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1565-1571

← 1 →